Note: This sentence appears on the guidelines and unmet-need pages of the Leqvio HCP site, as captured on November 14, 2026. The Prescribing Information (revised 08/2026) does not include it.
Study results
How much does Leqvio lower LDL-C vs placebo in ASCVD (ORION-10)?
Note: Table 2 gives the placebo row, the LEQVIO row, and the difference from placebo (LS mean, 95% CI), each in the column order LDL-C, total cholesterol, non-HDL-C, and ApoB; values are mean percentage change from baseline to Day 510.
How many patients reached LDL-C below 70 mg/dL on Leqvio (ORION-10)?
Note: The trial targets are those defined in the footnote; the Leqvio HCP site states that they align with the 2018 AHA/ACC cholesterol guideline. The site gives the 2026 guideline targets separately (see the question on the 2026 guideline LDL-C targets).
How much did Leqvio lower LDL-C vs placebo in ORION-11?
This passage is in a collapsed section of the page; select: Adults with hypercholesterolemia and ASCVD or at increased risk of CVD in ORION-11
Note: The trial targets are those defined in the footnote; the Leqvio HCP site states that they align with the 2018 AHA/ACC cholesterol guideline. The site gives the 2026 guideline targets separately (see the question on the 2026 guideline LDL-C targets).
Does Leqvio lower LDL-C after acute coronary syndrome vs usual care (V-INCEPTION)?